Recently diagnosed with HIV? Click here

Positive Living October 2006

Cover Story

Time to deliver

Positive Living article — Thursday, 5 October 2006

The 16th International AIDS Conference highlighted numerous important and promising developments in HIV treatments. JOHN DAYE reports. read more »

Tags: brecanavir, darunavir, drug resistance, enfuvirtide (T-20), entry and fusion inhibitors, etravirine (TMC-125), ibalizumab (TNX-355), Lipodystrophy and lipoatrophy, maraviroc, peripheral neuropathy, raltegravir, stress, depression, anxiety, uridine, vicriviroc

News

Improved Kaletra listed on the PBS

Positive Living article • Paul Kidd • 5 October 2006

A new, more convenient and better-tolerated version of the protease inhibitor Kaletra (lopinavir/ritonavir) is now available for S100 prescription on the PBS[Pharmaceutical Benefits Scheme] The federal government program which subsidises medication costs in Australia. Anti-HIV drugs are part of a special part of the PBS called Section 100 (S100) which is used for expensive, highly specialised drugs.. The new formulation comes in tablet form, requires no refrigeration and reduces the number of pills taken per day from six to four. read more »

Changes coming for Positive Living in 2007

Positive Living article • Paul Kidd • 5 October 2006

For more than 15 years, Positive Living has been an important source of information for positive people in Australia. From next year, important changes are planned that will ensure the publication’s long-term viability and improve the range and timeliness of information NAPWA provides. read more »

Feature

Reflections on the 2006 IAC Conference in Toronto

Positive Living article • John Rock • 5 October 2006

While there has been “slow but useful progress on many fronts,” the global response to HIV/AIDS is still too slow and too weak, writes JOHN ROCK. read more »

Futures 5: an improving picture, but only just

Positive Living article • Paul Kidd • 5 October 2006

People living with HIV are doing better on treatments and are more likely to be in employment than they were two years ago, but many are still living in poverty and increasingly concerned about the long-term impact of HIV treatments, according to the latest HIV Futures report. read more »

Text size: font smallerfont normalfont larger print-friendly version of this pagePDF version of this pageemail this page to a friend

From Positive Living

Positive Living is NAPWA's national HIV treatments publication, published four times a year. More information.

You can read PL on this website, subscribe to our free email version, or pick up a free copy in your local gay and lesbian community newspaper. If you'd rather receive PL through the post, we are happy to provide a free subscription to positive people anywhere in Australia.

Positive Living is distributed with generous assistance from Gilead Sciences and GlaxoSmithKline.
Gilead and GlaxoSmithKline logos

Download PDF version

AttachmentSize
PDF version of this issue929.79 KB

HIV Clinical Trials update

Recently updated entries from the NAPWA Clinical Trials database.

more